The dynamics of prostaglandin H synthases. Studies with prostaglandin h synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 9488715)

Published in J Biol Chem on March 06, 1998

Authors

O Y So1, L E Scarafia, A Y Mak, O H Callan, D C Swinney

Author Affiliations

1: Inflammatory Diseases Unit, Roche Bioscience, Palo Alto, California 94304, USA.

Articles citing this

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Proc Natl Acad Sci U S A (2000) 1.75

Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J (1999) 1.64

Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev (2011) 1.56

PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. J Physiol (2006) 1.25

The structural basis of endocannabinoid oxygenation by cyclooxygenase-2. J Biol Chem (2011) 1.16

A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochem J (2001) 1.14

Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition. Proc Natl Acad Sci U S A (2010) 1.12

A computational protocol for the integration of the monotopic protein prostaglandin H2 synthase into a phospholipid bilayer. Biophys J (2006) 0.88

Role of Tyr348 in Tyr385 radical dynamics and cyclooxygenase inhibitor interactions in prostaglandin H synthase-2. Biochemistry (2006) 0.88

Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms. Biochem J (2004) 0.86

Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands. J Comput Aided Mol Des (2006) 0.85

Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2). J Comput Aided Mol Des (2000) 0.78

Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs. J Comput Aided Mol Des (2002) 0.77

Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells. PLoS One (2017) 0.75

Articles by these authors

The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen. J Biol Chem (1996) 1.13

Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid. J Biol Chem (1997) 1.02

Structural characterization of arachidonyl radicals formed by prostaglandin H synthase-2 and prostaglandin H synthase-1 reconstituted with mangano protoporphyrin IX. J Biol Chem (1998) 0.95

Stereoisomers of ketoconazole: preparation and biological activity. J Med Chem (1992) 0.93

Androgen formation by cytochrome P450 CYP17. Solvent isotope effect and pL studies suggest a role for protons in the regulation of oxene versus peroxide chemistry. Biochemistry (1994) 0.91

Pharmacology of a Ca(2+)-influx pathway activated by emptying the intracellular Ca2+ stores in HL-60 cells: evidence that a cytochrome P-450 is not involved. Biochem J (1994) 0.91

Cloning and functional expression of the cDNA encoding rat lanosterol 14-alpha demethylase. Gene (1995) 0.87

Isotopically labeled chlorobenzenes as probes for the mechanism of cytochrome P-450 catalyzed aromatic hydroxylation. Biochemistry (1989) 0.86

Mechanism of androstenedione formation from testosterone and epitestosterone catalyzed by purified cytochrome P-450b. J Biol Chem (1988) 0.85

Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity. Biochem Pharmacol (1995) 0.84

Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering. J Med Chem (1993) 0.80

Quantitative expression analysis of the cellular specificity of HECT-domain ubiquitin E3 ligases. Physiol Genomics (2000) 0.78

Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A. Drug Metab Dispos (1993) 0.75

Intramolecular isotope effects associated with meta-hydroxylation of biphenyl catalyzed by cytochrome P-450. Biochem Biophys Res Commun (1984) 0.75